27.10.2014 15:37:51

The Asset Quality Review and stress test: where to next? - News by European Banks Analyst Justin Bisseker

Template Schroders on Axel Springer

iPad small mirrowed

News on TalkingPoint

The Asset Quality Review and stress test: where to next?

October 2014

Justin Bisseker, European Banks Analyst, looks at the results of the tests and some of the more subtle conclusions he expects the equity market to focus on.

The weekend has seen much excitement for European bank watchers with yesterday's release of the conclusions of the Asset Quality Review (AQR) and stress test. Both parts of the exercise should be of interest to investors, although much of the media interest thus far has just been on who has passed and who has failed.

So, what has been done? Firstly, the European Central Bank (ECB) has conducted an in-depth review of bank balance sheets ahead of its taking the helm as the eurozone's banking regulator next month. This has certainly been a detailed process - far more so than any investor could reasonably undertake. More than 119,000 borrower files and 170,000 collateral valuations were reviewed across 130 eurozone banks to ensure a uniform provisioning methodology and harmonised definitions. 18% of these credit files required some form of adjustment. These results were then extrapolated such that the majority of banks' material portfolios were covered in detail. Banks are required to maintain a 'phased' core Tier 1 capital ratio in excess of 8% post any required adjustments.
(...)

Read full article

For further topics please have a look at

Enjoy reading. Kind regards,
Schroders Switzerland

Important Information:

The views and opinions contained herein are those of the author and may not necessarily represent views expressed or reflected in other Schroders communications, strategies or funds.
For press and professional investors and advisors only. This document is not suitable for retail clients.

This document is intended to be for information purposes only and it is not intended as promotional material in any respect. The material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The material is not intended to provide, and should not be relied on for, accounting, legal or tax advice, or investment recommendations. Information herein is believed to be reliable but Schroders does not warrant its completeness or accuracy. The data has been sourced by Schroders and should be independently verifîed prior to further publication or use. No responsibility can be accepted for errors of fact or opinion. This does not exclude or restrict any duty or liability that Schroders has to its customers under the Financial Services and Markets Act 2000 (as amended from time to time) or any other regulatory system.

Past performance is not a guide to future performance and may not be repeated. The value of investments and the income from them can go down as well as up and investors may not get back the amount originally invested. Changes in exchange rates can also cause the value of investments in currencies. Investments in emerging markets can involve a higher degree of risk. Less developed markets are generally less well regulated than the Switzerland, investments may be less liquid and there may be less reliable arrangements for trading and settlement of the underlying holdings.

Issued by Schroder Investment Management (Switzerland) AG, Central 2, CH-8001 Zurich which is authorised and regulated by the FINMA.

© Schroders plc | www.schroders.ch

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sika	157.85	3.92 %	K V
Holcim	74.58	3.21 %	K V
Alcon	63.54	3.18 %	K V
CieFinRichemont	169.30	1.68 %	K V
Part Grp Hldg	928.60	0.13 %	K V
ABB	55.76	0.00 %	K V
Givaudan	3’333.00	-0.27 %	K V
Logitech Intl	90.24	-0.44 %	K V
Nestle	79.93	-0.76 %	K V

mehr

Fondsname Fondsgesellschaft

Fondsart

Ausgabeaufschlag

Mindestalter

Währung

Jahresperformance

Volumen

Sortieren nach

Novo Nordisk-Aktie tiefrot: Preisdruck und gescheiterte Alzheimer-Studien

TKMS-Aktie unter Druck: Anleger reagieren auf neue Analystenbewertungen

Aktien von CureVac und BionTech im Fokus: Aktionäre stimmen heute über Übernahme ab

Alphabet-Aktie im Fokus: KI-Boom, Buffett-Einstieg und starke Quartalszahlen treiben Kurs

Rheinmetall-Aktie höher: Investition in Mixed-Reality-Technologie - auch Aktien von HENSOLDT und RENK steigen

NIO-Aktie dennoch in Rot: Tesla-Konkurrent reduziert Verlust - Umsatzwachstum in Q3

Neue Analyse: Bernstein Research bewertet Rheinmetall-Aktie mit Market-Perform

Julius Bär-Aktie tiefrot: Neue Compliance-Chefin & Ausbau im Nahen Osten

Deutsche Telekom setzt Aktienrückkauf fort - Aktie schwächer

Ausblick: Alibaba-Aktie präsentiert Bilanzzahlen zum jüngsten Jahresviertel

Datum	Titel
18:28	Wadephul an Israel: Mehr Hilfe in Gazastreifen lassen
18:23	Aktien Wien Schluss: ATX gewinnt weiter - Ukraine stimmt Friedensplan zu
18:22	ROUNDUP/Aktien Europa Schluss: Gewinne - Hoffnung auf Ende des Ukraine-Krieges
18:13	US-Anleihen: Kursgewinne
18:04	Aktien Europa Schluss: Gewinne - Hoffnung auf baldiges Ende des Ukraine-Krieges
18:01	Deutsche Anleihen: Leichte Kursgewinne
18:03	thyssenkrupp-Aktie: Verkauf der Stahlsparte - IG Metall verlangt Garantien
17:59	ROUNDUP 3: Familienunternehmer laden AfD ein - scharfe Kritik
17:52	ROUNDUP/Aktien Frankfurt Schluss: Gewinne - Ukraine stimmt Friedensplan zu
17:45	Aktien Frankfurt Schluss: Gewinne - Ukraine stimmt Friedensplan zu